Cargando…

Tumour necrosis factor‐α inhibition can stabilize disease in progressive vitiligo

Tumour necrosis factor (TNF)‐α, a proinflammatory cytokine central to many autoimmune diseases, has been implicated in the depigmentation process in vitiligo. We review its role in vitiligo by exploring its pro‐ and anti‐inflammatory properties and examine the effects of blocking its actions with TN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Webb, K.C., Tung, R., Winterfield, L.S., Gottlieb, A.B., Eby, J.M., Henning, S.W., Le Poole, I.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583813/ https://www.ncbi.nlm.nih.gov/pubmed/26149498 http://dx.doi.org/10.1111/bjd.14016

Ejemplares similares

CCL22 to activate Treg migration and suppress depigmentation in vitiligo
por: Eby, Jonathan M., et al.
Publicado: (2015)

Stability in Vitiligo? What's that?
por: Lahiri, Koushik
Publicado: (2009)

Antigen Specificity Enhances Disease Control by Tregs in Vitiligo
por: Mukhatayev, Zhussipbek, et al.
Publicado: (2020)

A Study of Single Nucleotide Polymorphisms of Tumour Necrosis Factor α-1031 And Tumour Necrosis Factor β+ 252 in Chronic Rhinosinusitis
por: Misron, Khairunnisak, et al.
Publicado: (2017)

A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo
por: Chatterjee, Shilpak, et al.
Publicado: (2013)

The Concept of Stability of Vitiligo: A Reappraisal
por: Lahiri, Koushik, et al.
Publicado: (2012)

Stability in Vitiligo: Why Such a Hullabaloo?
por: Gupta, Somesh
Publicado: (2009)

Editorial: Immunology of Vitiligo
por: Seneschal, Julien, et al.
Publicado: (2021)

The relationship between stress and vitiligo: Evaluating perceived stress and electronic medical record data
por: Henning, Steven W., et al.
Publicado: (2020)

Mammographic tumour features can reliably predict the long-term outcome of women with 1–14 mm invasive breast cancer: suggestions for revision of current therapeutic practice and the TNM classification system
por: Tabar, L, et al.
Publicado: (2004)

Stability in Vitiligo: Is there a Perfect Way to Predict it?
por: Sahni, Kanika, et al.
Publicado: (2013)

Disease Stability in Segmental and Non-Segmental Vitiligo
por: Taneja, Neha, et al.
Publicado: (2021)

HYPOTHESIS: ZINC CAN BE EFFECTIVE IN TREATMENT OF VITILIGO
por: Bagherani, Nooshin, et al.
Publicado: (2011)

Increased Tumor Necrosis Factor (TNF)-α and Its Promoter Polymorphisms Correlate with Disease Progression and Higher Susceptibility towards Vitiligo
por: Laddha, Naresh C., et al.
Publicado: (2012)

The Newest Hypothesis about Vitiligo: Most of the Suggested Pathogeneses of Vitiligo Can Be Attributed to Lack of One Factor, Zinc-α2-Glycoprotein
por: Bagherani, Nooshin
Publicado: (2012)

Tumor Necrosis Factor B (TNFB) Genetic Variants and Its Increased Expression Are Associated with Vitiligo Susceptibility
por: Laddha, Naresh C., et al.
Publicado: (2013)

Melanocyte-keratinocyte cross-talk in vitiligo
por: Touni, Ahmed Ahmed, et al.
Publicado: (2023)

Validation of the Vitiligo Noticeability Scale: a patient‐reported outcome measure of vitiligo treatment success
por: Batchelor, J.M., et al.
Publicado: (2016)

Chemical Vitiligo: A Subset of Vitiligo
por: Ghosh, Sanjay
Publicado: (2020)

Tumour necrosis factor-α in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

Vitiligo /
por: Valderrabano Guitian, Agustín
Publicado: (1987)

Vitiligo, hypothyroidism and cardiomyopathy
por: Gupta, Yashdeep, et al.
Publicado: (2012)

A Case of Segmental Vitiligo with Generalized Morphea Stabilized by Antimalarial Medication
por: Kim, Hee Jung, et al.
Publicado: (2016)

Tumour Necrosis Factor-α Production and Immune Cell Activation in Tuberculous Meningitis
por: Mastroianni, C. M., et al.
Publicado: (1994)

Vitíligo : revisión bibliográfica
por: Merales Aldana, Arturo
Publicado: (1995)

Vitiligo : revisión bibliográfica
por: Huerta Herrera, Alejandrina
Publicado: (2001)

The Vitiligo in Senegal
por: Niang, S. O., et al.
Publicado: (2012)

Inflammatory Vitiligo
por: Chang, Hua-Ching, et al.
Publicado: (2022)

Leucasmus or Vitiligo
por: Earle, Chas. W.
Publicado: (1880)

Study of thyroid disorders in vitiligo
por: Khiangte, Lalchamliani, et al.
Publicado: (2023)

Proteomic Analysis of the Serum of Patients with Stable Vitiligo and Progressive Vitiligo
por: Li, Yi-Lei, et al.
Publicado: (2018)

Follicular vitiligo: dermatoscopic features of a new subtype of vitiligo
por: Cabrera, Raúl, et al.
Publicado: (2019)

Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.
por: Fujimoto, S., et al.
Publicado: (1992)

In vivo isolated kidney perfusion with tumour necrosis factor α (TNF-α) in tumour-bearing rats
por: Veen, A H van der, et al.
Publicado: (1999)

Cloning, expression and characterization of biologically active feline tumour necrosis factor-α
por: Rimstad, Espen, et al.
Publicado: (1995)

The Relationship of Fever to Tumour Necrosis in the Rat
por: Allen, Ingrid V.
Publicado: (1964)

Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
por: Trentin, L., et al.
Publicado: (1995)

Effects of tumour necrosis factor-α on BrdU incorporation in cultured human enterocytes
por: McDevitt, J., et al.
Publicado: (1995)

Vitiligo-Associated Autoimmune Disorders: A Woman With Vitiligo and Incipient Hypothyroidism
por: Malik, Sara, et al.
Publicado: (2021)

Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
por: Dernfalk, J, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_n9u8s5fl2jmha2qcvk5jqgh0a0